Kexin Cao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, First Hospital of China Medical University, China Medical University · ORCID：0000-0001-6903-3896

发表论文 9 篇 · 总被引 287 次 · h-index 6

代表论文

• The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches (2023 · Basic Research in Cardiology · 被引 103)
• Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches (2024 · Pharmacological Research · 被引 62)
• Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy (2023 · Circulation Research · 被引 48)
• Research progress of Nedd4L in cardiovascular diseases (2022 · Cell Death Discovery · 被引 37)
• The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods (2024 · Biomedicine & Pharmacotherapy · 被引 18)
• Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseases (2024 · International Journal of Biological Macromolecules · 被引 10)